146 related articles for article (PubMed ID: 21689906)
1. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.
Séité JF; Guerrier T; Cornec D; Jamin C; Youinou P; Hillion S
J Autoimmun; 2011 Nov; 37(3):190-7. PubMed ID: 21689906
[TBL] [Abstract][Full Text] [Related]
2. IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
Liu BS; Stoop JN; Huizinga TW; Toes RE
J Immunol; 2013 Oct; 191(8):4086-94. PubMed ID: 24043893
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
4. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
5. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Dil N; Marshall AJ
Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
[TBL] [Abstract][Full Text] [Related]
9. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
10. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
11. B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells.
Maddur MS; Hegde P; Sharma M; Kaveri SV; Bayry J
Autoimmun Rev; 2011 Dec; 11(2):154-6. PubMed ID: 21864723
[TBL] [Abstract][Full Text] [Related]
12. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
14. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
15. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
16. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.
Pagni PP; Traub S; Demaria O; Chasson L; Alexopoulou L
Autoimmunity; 2010 Jun; 43(4):275-87. PubMed ID: 20187710
[TBL] [Abstract][Full Text] [Related]
17. Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways.
Zhan Y; Xu Y; Seah S; Brady JL; Carrington EM; Cheers C; Croker BA; Wu L; Villadangos JA; Lew AM
J Immunol; 2010 Aug; 185(4):2125-33. PubMed ID: 20644172
[TBL] [Abstract][Full Text] [Related]
18. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
[TBL] [Abstract][Full Text] [Related]
19. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
20. Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes.
Younesi V; Nikzamir H; Yousefi M; Khoshnoodi J; Arjmand M; Rabbani H; Shokri F
Microbiol Immunol; 2010 Sep; 54(9):534-41. PubMed ID: 20840152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
